68Ga-PSMA PET/CT imaging in primary hepatocellular carcinoma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 43, Issue 4, 2016, Pages 795-796

  Sasikumar, Arun ^a   Joy, Ajith ^a   Nanabala, Raviteja ^a   Pillai, M R A ^a   Thomas, Boben ^b   Vikraman, K R ^b  

^a KIMS DDNMRC   (India)

^b KIMS Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM 68; PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; SORAFENIB; (68GA)GLU-UREA-LYS(AHX)-HBED-CC; ORGANOMETALLIC COMPOUND; RADIOPHARMACEUTICAL AGENT;

AGED; ANOREXIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; HEPATOMEGALY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; MALE; WEIGHT REDUCTION; DIAGNOSTIC IMAGING; LIVER TUMOR; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; X-RAY COMPUTED TOMOGRAPHY;

AGED; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; MALE; MULTIMODAL IMAGING; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84959091117     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-015-3297-x     Document Type: Article

References (5)

1. Afshar Oromieh A, Avtzi E, Giesel FL, HollandLetz T, Linhart HG, Eder M, et al. The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2015;42:197–209.
2. Demirci E, Ocak M, Kabasakal L, Decristoforo C, Talat Z, Halaç M, et al. (68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma. Eur J Nucl Med Mol Imaging. 2014;41:1461–2.
3. Sathekge M, Modiselle M, Vorster M, Mokgoro N, Nyakale N, Mokaleng B, et al. 68Ga-PSMA imaging of metastatic breast cancer. Eur J Nucl Med Mol Imaging. 2015;42:1482–3.
4. Nomura N, Pastorino S, Jiang P, Lambert G, Crawford JR, Gymnopoulos M, et al. Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases. Cancer Cell Int. 2014;14:26.
5. Denmeade SR, Mhaka AM, Rosen DM, Brennen WN, Dalrymple S, Dach I, et al. Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy. Sci Transl Med. 2012;4:140ra86. doi:10.1126/scitranslmed.3003886.